-
Heplisav-B 2021 report
Heplisav-B 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 29 Pages The 5 Key Questions Addressed by this Report:...
-
Pediarix 2021 report
Pediarix 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this Report:...
-
Horizant 2020 report
Horizant 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 30 Pages The 5 Key Questions Addressed by this Report:...
-
Perseris 2020 report
Perseris 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 19 Pages The 5 Key Questions Addressed by this Report:...
-
Heplisav-B 2019 report
Heplisav-B 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...
-
Pediarix 2019 report
Pediarix 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this Report:...
-
Engerix 2018 report
Engerix 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...
-
Heplisav-B 2018 report
Heplisav-B 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...
-
Pediarix 2018 report
Pediarix 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...
-
Recombivax HB 2018 report
Recombivax HB 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this...
-
Engerix 2017 report
Engerix 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...
-
Pediarix 2017 report
Pediarix 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...